Accessibility Menu
 

Evommune

(NYSE) EVMN

Current Price$23.58
Market Cap$854.36M
Since IPO (2025)+17%
5 YearN/A
1 YearN/A
1 Month-1%

Evommune Financials at a Glance

Market Cap

$854.36M

Revenue (TTM)

$13.00M

Net Income (TTM)

$68.87M

EPS (TTM)

$-2.23

P/E Ratio

-10.65

Dividend

$0.00

Beta (Volatility)

1.94 (High)

Price

$23.58

Volume

17,053

Open

$22.30

Previous Close

$23.58

Daily Range

$22.30 - $23.82

52-Week Range

$13.88 - $33.20

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Evommune

Industry

Biotechnology

Employees

48

CEO

Luis C. Peña

Headquarters

Palo Alto, CA 94304, US

EVMN Financials

Key Financial Metrics (TTM)

Gross Margin

89%

Operating Margin

-6%

Net Income Margin

-5%

Return on Equity

0%

Return on Capital

-39%

Return on Assets

-31%

Earnings Yield

-9.39%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$854.36M

Shares Outstanding

36.02M

Volume

17.05K

Short Interest

0.00%

Avg. Volume

631.48K

Financials (TTM)

Gross Profit

$11.61M

Operating Income

$81.07M

EBITDA

$79.68M

Operating Cash Flow

$76.44M

Capital Expenditure

$235.00K

Free Cash Flow

$76.68M

Cash & ST Invst.

$149.20M

Total Debt

$2.06M

Evommune Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$326.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$854.36M

N/A

Market Cap/Employee

$18.99M

N/A

Employees

45

N/A

Net Income

$28.27M

-54.3%

EBITDA

$29.39M

-57.7%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$147.14M

+108.2%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$1.47M

-99.2%

Short Term Debt

$589.00K

-68.6%

Return on Assets

-30.62%

N/A

Return on Invested Capital

-39.16%

N/A

Free Cash Flow

$16.80M

+24.9%

Operating Cash Flow

$16.70M

+25.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
FTREFortrea Holdings Inc.
$9.45-0.63%
EYPTEyePoint Pharmaceuticals, Inc.
$13.40+2.92%
CLYMClimb Bio, Inc.
$6.56-5.61%
OABIOmniAb, Inc.
$1.54-1.28%

Trending Stocks

Symbol / CompanyPricePrice Chg
SKYQSky Quarry
$5.10+1.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.37-0.11%
INTCIntel
$50.38+0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.33+0.00%

Questions About EVMN

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.